Rtw Investments as of Sept. 30, 2015
Portfolio Holdings for Rtw Investments
Rtw Investments holds 42 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 13.4 | $43M | 534k | 80.36 | |
| Incyte Corporation (INCY) | 10.5 | $34M | 303k | 110.33 | |
| La Jolla Pharmaceuticl Com Par | 9.4 | $30M | 1.1M | 27.79 | |
| BioCryst Pharmaceuticals (BCRX) | 8.0 | $25M | 2.2M | 11.40 | |
| Kite Pharma | 6.5 | $21M | 376k | 55.68 | |
| Achillion Pharmaceuticals | 5.6 | $18M | 2.6M | 6.91 | |
| Mirati Therapeutics | 5.2 | $17M | 482k | 34.42 | |
| Dicerna Pharmaceuticals | 5.2 | $17M | 2.0M | 8.21 | |
| Bluebird Bio (BLUE) | 4.1 | $13M | 152k | 85.55 | |
| Arrowhead Resh | 3.8 | $12M | 2.1M | 5.76 | |
| Five Prime Therapeutics | 3.4 | $11M | 714k | 15.39 | |
| Agenus | 3.0 | $9.6M | 2.1M | 4.60 | |
| Atara Biotherapeutics | 2.6 | $8.3M | 263k | 31.44 | |
| Celldex Therapeutics | 2.4 | $7.6M | 719k | 10.54 | |
| Symmetry Surgical | 2.2 | $7.2M | 807k | 8.90 | |
| Bristol Myers Squibb (BMY) | 2.0 | $6.5M | 110k | 59.20 | |
| Omeros Corporation (OMER) | 1.7 | $5.4M | 490k | 10.96 | |
| Corium Intl | 1.7 | $5.4M | 575k | 9.35 | |
| Regenxbio Inc equity us cm (RGNX) | 1.4 | $4.5M | 205k | 22.03 | |
| Global Blood Therapeutics In | 1.2 | $3.9M | 92k | 42.16 | |
| Lipocine | 0.8 | $2.5M | 213k | 11.83 | |
| Invuity | 0.8 | $2.5M | 175k | 14.02 | |
| Dyax | 0.7 | $2.2M | 115k | 19.09 | |
| Presbia | 0.6 | $1.9M | 350k | 5.48 | |
| Catalyst Biosciences | 0.6 | $1.8M | 381k | 4.66 | |
| Repros Therapeutics | 0.5 | $1.7M | 233k | 7.43 | |
| Vbi Vaccines | 0.5 | $1.7M | 650k | 2.64 | |
| OraSure Technologies (OSUR) | 0.5 | $1.4M | 323k | 4.44 | |
| Cytrx | 0.3 | $1.1M | 454k | 2.37 | |
| Newlink Genetics Corporation | 0.3 | $1.0M | 28k | 35.84 | |
| Masimo Corporation (MASI) | 0.3 | $999k | 26k | 38.57 | |
| Allscripts Healthcare Solutions (MDRX) | 0.2 | $595k | 48k | 12.40 | |
| Biopharmx | 0.1 | $382k | 371k | 1.03 | |
| Nivalis Therapeutics | 0.1 | $389k | 30k | 12.97 | |
| Natera (NTRA) | 0.1 | $344k | 32k | 10.85 | |
| Genomic Health | 0.1 | $317k | 15k | 21.13 | |
| Endologix | 0.1 | $184k | 15k | 12.27 | |
| Veracyte (VCYT) | 0.0 | $117k | 25k | 4.68 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $84k | 7.0k | 11.95 | |
| Meridian Bioscience | 0.0 | $50k | 1.3k | 39.94 | |
| United States Oil Fund | 0.0 | $42k | 14k | 3.03 | |
| Berkshire Hath-cl B | 0.0 | $7.0k | 50.00 | 140.00 |
